These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23939625)

  • 1. Clonal selection and persistence in dysplastic Barrett's esophagus and intramucosal cancers after failed radiofrequency ablation.
    Zeki SS; Haidry R; Graham TA; Rodriguez-Justo M; Novelli M; Hoare J; Dunn J; Wright NA; Lovat LB; McDonald SA
    Am J Gastroenterol; 2013 Oct; 108(10):1584-92. PubMed ID: 23939625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathology of Barrett's esophagus after ablation and endoscopic mucosal resection therapy.
    Odze RD; Lauwers GY
    Endoscopy; 2008 Dec; 40(12):1008-15. PubMed ID: 19065484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing outcome of radiofrequency ablation in Barrett's with high grade dysplasia and intramucosal carcinoma: a prospective multicenter UK registry.
    Haidry RJ; Lipman G; Banks MR; Butt MA; Sehgal V; Graham D; Dunn JM; Gupta A; Sweis R; Miah H; Morris D; Smart HL; Bhandari P; Willert R; Fullarton G; Morris J; Di Pietro M; Gordon C; Penman I; Barr H; Patel P; Boger P; Kapoor N; Mahon B; Hoare J; Narayanasamy R; O'Toole D; Cheong E; Direkze NC; Ang Y; Veitch A; Dhar A; Nyalender D; Ragunath K; Leahy A; Fullard M; Rodriguez-Justo M; Novelli M; Lovat LB
    Endoscopy; 2015 Nov; 47(11):980-7. PubMed ID: 26126159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic therapy using radiofrequency ablation for esophageal dysplasia and carcinoma in Barrett's esophagus.
    van Vilsteren FG; Bergman JJ
    Gastrointest Endosc Clin N Am; 2010 Jan; 20(1):55-74, vi. PubMed ID: 19951794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiofrequency ablation for Barrett's-associated intramucosal carcinoma: a multi-center follow-up study.
    Strauss AC; Agoston AT; Dulai PS; Srivastava A; Rothstein RI
    Surg Endosc; 2014 Dec; 28(12):3366-72. PubMed ID: 24950726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudo-buried Barrett's post radiofrequency ablation for Barrett's esophagus, with or without prior endoscopic resection.
    Pouw RE; Visser M; Odze RD; Sondermeijer CM; ten Kate FJ; Weusten BL; Bergman JJ
    Endoscopy; 2014 Feb; 46(2):105-9. PubMed ID: 24285123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetic analysis of surveillance biopsy samples from Barrett's mucosa--significance of sampling.
    Werther M; Saure C; Pahl R; Schorr F; Rüschoff J; Alles JU; Heinmöller E
    Pathol Res Pract; 2008; 204(5):285-94. PubMed ID: 18337019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Esophageal motility and impedance characteristics in patients with Barrett's esophagus before and after radiofrequency ablation.
    Hemmink GJ; Alvarez Herrero L; Bogte A; Bredenoord AJ; Bergman JJ; Smout AJ; Weusten BL
    Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1024-32. PubMed ID: 23708277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiofrequency ablation and endoscopic mucosal resection for dysplastic barrett's esophagus and early esophageal adenocarcinoma: outcomes of the UK National Halo RFA Registry.
    Haidry RJ; Dunn JM; Butt MA; Burnell MG; Gupta A; Green S; Miah H; Smart HL; Bhandari P; Smith LA; Willert R; Fullarton G; Morris J; Di Pietro M; Gordon C; Penman I; Barr H; Patel P; Boger P; Kapoor N; Mahon B; Hoare J; Narayanasamy R; O'Toole D; Cheong E; Direkze NC; Ang Y; Novelli M; Banks MR; Lovat LB
    Gastroenterology; 2013 Jul; 145(1):87-95. PubMed ID: 23542069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management.
    Chennat J; Ross AS; Konda VJ; Lin S; Noffsinger A; Hart J; Waxman I
    Gastrointest Endosc; 2009 Sep; 70(3):417-21. PubMed ID: 19555948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA profile in neosquamous esophageal mucosa following ablation of Barrett's esophagus.
    Sreedharan L; Mayne GC; Watson DI; Bright T; Lord RV; Ansar A; Wang T; Kist J; Astill DS; Hussey DJ
    World J Gastroenterol; 2017 Aug; 23(30):5508-5518. PubMed ID: 28852310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett's esophagus: results from a US Multicenter Consortium.
    Gupta M; Iyer PG; Lutzke L; Gorospe EC; Abrams JA; Falk GW; Ginsberg GG; Rustgi AK; Lightdale CJ; Wang TC; Fudman DI; Poneros JM; Wang KK
    Gastroenterology; 2013 Jul; 145(1):79-86.e1. PubMed ID: 23499759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysplasia in Barrett's esophagus. A clinicopathologic study of six patients.
    Lee RG
    Am J Surg Pathol; 1985 Dec; 9(12):845-52. PubMed ID: 2416226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence of subsquamous dysplasia and carcinoma after successful endoscopic and radiofrequency ablation therapy for dysplastic Barrett's esophagus.
    Lee JK; Cameron RG; Binmoeller KF; Shah JN; Shergill A; Garcia-Kennedy R; Bhat YM
    Endoscopy; 2013 Jul; 45(7):571-4. PubMed ID: 23592390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of buried Barrett's glands after radiofrequency ablation with volumetric laser endomicroscopy.
    Swager AF; Boerwinkel DF; de Bruin DM; Faber DJ; van Leeuwen TG; Weusten BL; Meijer SL; Bergman JJ; Curvers WL
    Gastrointest Endosc; 2016 Jan; 83(1):80-8. PubMed ID: 26124075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
    Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
    Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoscopic submucosal dissection plus radiofrequency ablation of neoplastic Barrett's esophagus.
    Neuhaus H; Terheggen G; Rutz EM; Vieth M; Schumacher B
    Endoscopy; 2012 Dec; 44(12):1105-13. PubMed ID: 22968641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Durability of radiofrequency ablation in Barrett's esophagus with dysplasia.
    Shaheen NJ; Overholt BF; Sampliner RE; Wolfsen HC; Wang KK; Fleischer DE; Sharma VK; Eisen GM; Fennerty MB; Hunter JG; Bronner MP; Goldblum JR; Bennett AE; Mashimo H; Rothstein RI; Gordon SR; Edmundowicz SA; Madanick RD; Peery AF; Muthusamy VR; Chang KJ; Kimmey MB; Spechler SJ; Siddiqui AA; Souza RF; Infantolino A; Dumot JA; Falk GW; Galanko JA; Jobe BA; Hawes RH; Hoffman BJ; Sharma P; Chak A; Lightdale CJ
    Gastroenterology; 2011 Aug; 141(2):460-8. PubMed ID: 21679712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of Dysplastic Barrett's Esophagus and Early Esophageal Adenocarcinoma.
    Cotton CC; Eluri S; Shaheen NJ
    Gastroenterol Clin North Am; 2022 Sep; 51(3):485-500. PubMed ID: 36153106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of invasive cancer after endoscopic treatment of Barrett's esophagus with high-grade dysplasia and intramucosal cancer in physiologically fit patients: time for a review of surveillance and treatment guidelines.
    Templeton A; Bodnar A; Gan SI; Irani S; Ross A; Low D
    Gastrointest Endosc; 2014 May; 79(5):839-44. PubMed ID: 24447341
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.